You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
金斯瑞生物科技(01548.HK):傳奇生物就出售普通股及認股權證訂立認購協議
格隆匯 05-14 07:55

格隆匯5月14日丨金斯瑞生物科技(01548.HK)發佈公吿,該公司非全資附屬公司傳奇生物科技股份有限公司(其股份以美國存托股份形式於美國納斯達克全球精選市場上市)已於2021年5月13日(美國東部時間)向美國證監會提交6-K表格,內容有關就出售傳奇普通股及可行使為傳奇普通股的認股權證訂立一份認購協議。

5月13日,傳奇生物科技股份有限公司(“公司”)就於私募發售中發售及出售20,809,850股普通股與一名機構投資者訂立一份認購協議,購買價為每股普通股14.41625美元(相當於每股美國存托股份28.8325美元)(“私募發售”)。

根據認購協議,公司亦同意在私募發售的同時發行及出售一份認股權證,可行使以認購最多合共1000萬股普通股。認股權證將可按每股普通股20.00美元(相當於每股美國存托股份40.00美元)的行使價全部或部分行使。認股權證將可於完成日期後及完成日期兩週年前行使。

公司亦授予該投資者有關於私募發售中收購的普通股及於認股權證獲行使時須予發行的普通股的慣常登記權。待達成慣常完成條件後,該等交易預期於5月19日或前後完成。私募發售完成後,Genscript Biotech Corporation將實益擁有公司普通股的58.31%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account